ALT 0 3 0 3 B-clinical_variable
and 4 7 4 7 O
either 8 14 8 14 O
alkaline 15 23 15 23 B-clinical_variable
phosphatase 24 35 24 35 I-clinical_variable
or 36 38 36 38 O
GGT 39 42 39 42 B-clinical_variable
remain 43 49 43 49 O
within 50 56 50 56 O
normal 57 63 57 63 O
limits 64 70 64 70 O
or 71 73 71 73 O
< 74 75 74 75 O
\\= 75 78 75 78 O
1.5 79 82 79 82 I-upper_bound
x 83 84 83 84 O
baseline 85 93 85 93 O
after 94 99 94 99 I-treatment
darTregs 100 108 100 108 I-treatment
infusion 109 117 109 117 I-treatment

An 0 2 118 120 O
episode 3 10 121 128 O
of 11 13 129 131 O
Acute 14 19 132 137 B-clinical_variable
Rejection 20 29 138 147 I-clinical_variable
( 30 31 148 149 I-clinical_variable
AR 31 33 149 151 I-clinical_variable
) 33 34 151 152 I-clinical_variable
within 35 41 153 159 O
one 42 45 160 163 B-upper_bound
year 46 50 164 168 I-upper_bound
of 51 53 169 171 O
enrollment 54 64 172 182 O

Any 0 3 183 186 O
chronic 4 11 187 194 B-chronic_disease
condition 12 21 195 204 I-chronic_disease
for 22 25 205 208 O
which 26 31 209 214 O
anti 32 36 215 219 O
- 36 37 219 220 O
coagulation 37 48 220 231 O
can 49 52 232 235 O
not 52 55 235 238 O
be 56 58 239 241 O
safely 59 65 242 248 O
interrupted 66 77 249 260 O
for 78 81 261 264 O
liver 82 87 265 270 B-treatment
biopsy 88 94 271 277 I-treatment

Any 0 3 278 281 O
other 4 9 282 287 O
condition 10 19 288 297 O
, 19 20 297 298 O
in 21 23 299 301 O
the 24 27 302 305 O
investigator 28 40 306 318 O
's 40 42 318 320 O
judgment 43 51 321 329 O
, 51 52 329 330 O
that 53 57 331 335 O
increases 58 67 336 345 O
the 68 71 346 349 O
risk 72 76 350 354 O
of 77 79 355 357 O
darTregs 80 88 358 366 B-treatment
infusion 89 97 367 375 I-treatment
or 98 100 376 378 O
prevents 101 109 379 387 O
safe 110 114 388 392 O
trial 115 120 393 398 O
participation 121 134 399 412 O

Any 0 3 413 416 O
vaccination 4 15 417 428 B-treatment
given 16 21 429 434 O
within 22 28 435 441 O
28 29 31 442 444 B-upper_bound
days 32 36 445 449 I-upper_bound
prior 37 42 450 455 I-upper_bound
to 43 45 456 458 O
Treg 46 50 459 463 O
collection 51 61 464 474 O
for 62 65 475 478 O
Treg 66 70 479 483 O
production 71 81 484 494 O

Be 0 2 495 497 O
36 3 5 498 500 B-lower_bound
months 6 12 501 507 I-lower_bound
or 13 15 508 510 O
more 16 20 511 515 O
post 21 25 516 520 O
- 25 26 520 521 O
transplant 26 36 521 531 B-treatment

Calculated 0 10 532 542 B-clinical_variable
Glomerular 11 21 543 553 I-clinical_variable
filtration 22 32 554 564 I-clinical_variable
rate 33 37 565 569 I-clinical_variable
( 38 39 570 571 I-clinical_variable
GFR 39 42 571 574 I-clinical_variable
) 42 43 574 575 I-clinical_variable
less 44 48 576 580 O
than 49 53 581 585 O
50 54 56 586 588 B-upper_bound
mL 57 59 589 591 I-upper_bound
/ 59 60 591 592 I-upper_bound
min/1.73m^2 60 71 592 603 I-upper_bound
at 72 74 604 606 O
the 75 78 607 610 O
time 79 83 611 615 O
of 84 86 616 618 O
enrollment 87 97 619 629 O

Clinical 0 8 630 638 O
evidence 9 17 639 647 O
of 18 20 648 650 O
viral 21 26 651 656 B-clinical_variable
syndrome 27 35 657 665 I-clinical_variable
less 36 40 666 670 O
than 41 45 671 675 O
7 46 47 676 677 B-upper_bound
days 48 52 678 682 I-upper_bound
prior 53 58 683 688 B-treatment
to 59 61 689 691 I-treatment
darTregs 62 70 692 700 I-treatment
infusion 71 79 701 709 I-treatment

Confirmatory 0 12 710 722 O
CT 13 15 723 725 B-treatment
or 16 18 726 728 O
MRI 19 22 729 732 B-treatment
of 23 25 733 735 O
the 26 29 736 739 O
abdomen 30 37 740 747 O
and 38 41 748 751 O
pelvis 42 48 752 758 O

Confirmatory 0 12 759 771 O
chest 13 18 772 777 B-treatment
CT 19 21 778 780 I-treatment

Cured 0 5 781 786 O
of 6 8 787 789 O
HCV 9 12 790 793 B-chronic_disease
as 13 15 794 796 O
defined 16 23 797 804 O
by 24 26 805 807 O
achieving 27 36 808 817 O
Sustained 37 46 818 827 O
virologic 47 56 828 837 O
response 57 65 838 846 O
( 66 67 847 848 O
SVR 67 70 848 851 O
) 70 71 851 852 O
and 72 75 853 856 O
be 76 78 857 859 O
greater 79 86 860 867 O
than 87 91 868 872 O
or 92 94 873 875 O
equal 95 100 876 881 O
to 101 103 882 884 O
six 104 107 885 888 B-lower_bound
months 108 114 889 895 I-lower_bound
after 115 120 896 901 I-lower_bound
the 121 124 902 905 O
end 125 128 906 909 O
of 129 131 910 912 O
treatment 132 141 913 922 B-treatment

Currently 0 9 923 932 O
receiving 10 19 933 942 O
CNI 20 23 943 946 B-treatment
monotherapy 24 35 947 958 I-treatment
or 36 38 959 961 O
CNI 39 42 962 965 O

Currently 0 9 966 975 O
receiving 10 19 976 985 O
a 20 21 986 987 O
Calcineurin 22 33 988 999 B-clinical_variable
Inhibitor 34 43 1000 1009 I-clinical_variable
( 44 45 1010 1011 I-clinical_variable
CNI 45 48 1011 1014 I-clinical_variable
) 48 49 1014 1015 I-clinical_variable
with 50 54 1016 1020 O
12 55 57 1021 1023 O
hour 58 62 1024 1028 O
trough 63 69 1029 1035 O
levels 70 76 1036 1042 O
consistently 77 89 1043 1055 O
< 90 91 1056 1057 O
6.0 91 94 1057 1060 B-upper_bound
ng 95 97 1061 1063 I-upper_bound
/ 97 98 1063 1064 I-upper_bound
mL 98 100 1064 1066 I-upper_bound
for 101 104 1067 1070 O
tacrolimus 105 115 1071 1081 B-treatment
; 115 116 1081 1082 O
< 117 118 1083 1084 O
150 118 121 1084 1087 B-upper_bound
ng 122 124 1088 1090 I-upper_bound
/ 124 125 1090 1091 I-upper_bound
mL 125 127 1091 1093 I-upper_bound
for 128 131 1094 1097 O
cyclosporine 132 144 1098 1110 B-treatment

Diagnosis 0 9 1111 1120 O
of 10 12 1121 1123 O
AR 13 15 1124 1126 B-chronic_disease
after 16 21 1127 1132 O
initiation 22 32 1133 1143 O
of 33 35 1144 1146 O
IS 36 38 1147 1149 O
withdrawal 39 49 1150 1160 O

Eighteen 0 8 1161 1169 B-lower_bound
to 9 11 1170 1172 O
70 12 14 1173 1175 B-upper_bound
years 15 20 1176 1181 I-upper_bound
of 21 23 1182 1184 O
age 24 27 1185 1188 B-age
at 28 30 1189 1191 O
the 31 34 1192 1195 O
time 35 39 1196 1200 O
of 40 42 1201 1203 O
study 43 48 1204 1209 O
entry 49 54 1210 1215 O
/ 54 55 1215 1216 O
consent 55 62 1216 1223 O

Female 0 6 1224 1230 B-gender

For 0 3 1231 1234 O
subjects 4 12 1235 1243 O
with 13 17 1244 1248 O
elevated 18 26 1249 1257 O
liver 27 32 1258 1263 O
tests 33 38 1264 1269 O
as 39 41 1270 1272 O
defined 42 49 1273 1280 O
above 50 55 1281 1286 O
, 55 56 1286 1287 O
local 57 62 1288 1293 O
pathology 63 72 1294 1303 O
reading 73 80 1304 1311 O
of 81 83 1312 1314 O
liver 84 89 1315 1320 B-treatment
biopsy 90 96 1321 1327 I-treatment
6 97 98 1328 1329 B-lower_bound
- 98 99 1329 1330 O
10 99 101 1330 1332 B-upper_bound
days 102 106 1333 1337 I-upper_bound
after 107 112 1338 1343 I-upper_bound
darTregs 113 121 1344 1352 O
infusion 122 130 1353 1361 O
is 131 133 1362 1364 O
without 134 141 1365 1372 O
AR 142 144 1373 1375 O
according 145 154 1376 1385 O
to 155 157 1386 1388 O
Banff 158 163 1389 1394 O
criteria 164 172 1395 1403 O

For 0 3 1404 1407 O
subjects 4 12 1408 1416 O
with 13 17 1417 1421 O
hepatitis 18 27 1422 1431 B-chronic_disease
B 28 29 1432 1433 I-chronic_disease
virus 30 35 1434 1439 I-chronic_disease
( 36 37 1440 1441 I-chronic_disease
HBV 37 40 1441 1444 I-chronic_disease
) 40 41 1444 1445 I-chronic_disease
, 41 42 1445 1446 O
no 43 45 1447 1449 O
detectible 46 56 1450 1460 O
circulating 57 68 1461 1472 O
HBV 69 72 1473 1476 O
DNA 73 76 1477 1480 O
, 76 77 1480 1481 O
assessed 78 86 1482 1490 O
at 87 89 1491 1493 O
the 90 93 1494 1497 O
time 94 98 1498 1502 O
of 99 101 1503 1505 O
PBMC 102 106 1506 1510 O
collection 107 117 1511 1521 O
for 118 121 1522 1525 O
manufacture 122 133 1526 1537 O

For 0 3 1538 1541 O
subjects 4 12 1542 1550 O
with 13 17 1551 1555 O
hepatitis 18 27 1556 1565 B-chronic_disease
B 28 29 1566 1567 I-chronic_disease
, 29 30 1567 1568 O
detectible 31 41 1569 1579 O
hepatitis 42 51 1580 1589 B-chronic_disease
B 52 53 1590 1591 I-chronic_disease
virus 54 59 1592 1597 I-chronic_disease
( 60 61 1598 1599 I-chronic_disease
HBV 61 64 1599 1602 I-chronic_disease
) 64 65 1602 1603 I-chronic_disease
DNA 66 69 1604 1607 O

HCV 0 3 1608 1611 B-chronic_disease
RNA 4 7 1612 1615 O
negative 8 16 1616 1624 O
at 17 19 1625 1627 O
time 20 24 1628 1632 O
of 25 27 1633 1635 O
study 28 33 1636 1641 O
enrollment 34 44 1642 1652 O

Have 0 4 1653 1657 O
received 5 13 1658 1666 O
a 14 15 1667 1668 O
primary 16 23 1669 1676 O
, 23 24 1676 1677 O
solitary 25 33 1678 1686 O
, 33 34 1686 1687 O
living 35 41 1688 1694 B-treatment
donor 42 47 1695 1700 I-treatment
liver 48 53 1701 1706 I-treatment
transplant 54 64 1707 1717 I-treatment
more 65 69 1718 1722 O
24 70 72 1723 1725 B-lower_bound
months 73 79 1726 1732 I-lower_bound
and 80 83 1733 1736 O
less 84 88 1737 1741 O
than 89 93 1742 1746 O
84 94 96 1747 1749 B-upper_bound
months 97 103 1750 1756 I-upper_bound
ago 104 107 1757 1760 O

History 0 7 1761 1768 O
of 8 10 1769 1771 O
adequately 11 21 1772 1782 O
treated 22 29 1783 1790 O
in 30 32 1791 1793 B-cancer
- 32 33 1793 1794 I-cancer
situ 33 37 1794 1798 I-cancer
cervical 38 46 1799 1807 I-cancer
carcinoma 47 56 1808 1817 I-cancer
and/or 57 63 1818 1824 O
skin 64 68 1825 1829 B-cancer
cancer 69 75 1830 1836 I-cancer
( 76 77 1837 1838 O
basal 77 82 1838 1843 B-cancer
or 83 85 1844 1846 O
squamous 86 94 1847 1855 B-cancer
cell 95 99 1856 1860 I-cancer
) 99 100 1860 1861 O
will 101 105 1862 1866 O
be 106 108 1867 1869 O
permitted 109 118 1870 1879 O

History 0 7 1880 1887 O
of 8 10 1888 1890 O
malignancy 11 21 1891 1901 B-cancer
within 22 28 1902 1908 O
5 29 30 1909 1910 B-upper_bound
years 31 36 1911 1916 I-upper_bound
of 37 39 1917 1919 O
enrollment 40 50 1920 1930 O

IS 0 2 1931 1933 O
withdrawal 3 13 1934 1944 O
resumes 14 21 1945 1952 O
no 22 24 1953 1955 O
later 25 30 1956 1961 O
than 31 35 1962 1966 O
14 36 38 1967 1969 B-upper_bound
days 39 43 1970 1974 I-upper_bound
after 44 49 1975 1980 I-upper_bound
darTregs 50 58 1981 1989 B-treatment
infusion 59 67 1990 1998 I-treatment

Liver 0 5 1999 2004 O
function 6 14 2005 2013 O
test 15 19 2014 2018 O
( 20 21 2019 2020 O
LFT 21 24 2020 2023 O
) 24 25 2023 2024 O
results 26 33 2025 2032 O
: 33 34 2032 2033 O
have 35 39 2034 2038 O
Alanine 40 47 2039 2046 B-clinical_variable
Aminotransferase 48 64 2047 2063 I-clinical_variable
( 65 66 2064 2065 I-clinical_variable
ALT)consistently 66 82 2065 2081 I-clinical_variable
< 83 84 2082 2083 O
60 84 86 2083 2085 B-upper_bound
U 87 88 2086 2087 I-upper_bound
/ 88 89 2087 2088 I-upper_bound
L 89 90 2088 2089 I-upper_bound
and 91 94 2090 2093 O
either 95 101 2094 2100 O
alkaline 102 110 2101 2109 B-clinical_variable
phosphatase 111 122 2110 2121 I-clinical_variable
consistently 123 135 2122 2134 O
< 136 137 2135 2136 O
150 137 140 2136 2139 B-upper_bound
U 141 142 2140 2141 I-upper_bound
/ 142 143 2141 2142 I-upper_bound
L 143 144 2142 2143 I-upper_bound
or 145 147 2144 2146 O
Gamma 148 153 2147 2152 B-clinical_variable
- 153 154 2152 2153 I-clinical_variable
glutamyl 154 162 2153 2161 I-clinical_variable
transferase 163 174 2162 2173 I-clinical_variable
( 175 176 2174 2175 I-clinical_variable
GGT 176 179 2175 2178 I-clinical_variable
) 179 180 2178 2179 I-clinical_variable
consistently 181 193 2180 2192 O
< 194 195 2193 2194 O
60 195 197 2194 2196 O
U 198 199 2197 2198 O
/ 199 200 2198 2199 O
L 200 201 2199 2200 O

Mycophenolate 0 13 2201 2214 B-treatment
mofetil 14 21 2215 2222 I-treatment
( 22 23 2223 2224 I-treatment
MMF 23 26 2224 2227 I-treatment
): 26 28 2227 2229 I-treatment
maximum 29 36 2230 2237 O
dose 37 41 2238 2242 O
of 42 44 2243 2245 O
500 45 48 2246 2249 B-upper_bound
mg 49 51 2250 2252 I-upper_bound
administered 52 64 2253 2265 O
twice 65 70 2266 2271 B-upper_bound
daily 71 76 2272 2277 O
for 77 80 2278 2281 O
Cellcept 81 89 2282 2290 B-treatment
or 90 92 2291 2293 O
360 93 96 2294 2297 B-upper_bound
mg 96 98 2297 2299 I-upper_bound
twice 99 104 2300 2305 O
daily 105 110 2306 2311 O
for 111 114 2312 2315 O
Myfortic 115 123 2316 2324 B-treatment

No 0 2 2325 2327 O
detectible 3 13 2328 2338 O
circulating 14 25 2339 2350 O
EBV 26 29 2351 2354 B-chronic_disease
or 30 32 2355 2357 O
CMV 33 36 2358 2361 B-chronic_disease
DNA 37 40 2362 2365 O
prior 41 46 2366 2371 O
to 47 49 2372 2374 O
Treg 50 54 2375 2379 B-treatment
infusion 55 63 2380 2388 I-treatment
, 63 64 2388 2389 O
assessed 65 73 2390 2398 O
at 74 76 2399 2401 O
the 77 80 2402 2405 O
time 81 85 2406 2410 O
of 86 88 2411 2413 O
PBMC 89 93 2414 2418 O
collection 94 104 2419 2429 O
for 105 108 2430 2433 O
manufacture 109 120 2434 2445 O

Organ 0 5 2446 2451 B-treatment
, 5 6 2451 2452 O
tissue 7 13 2453 2459 B-treatment
or 14 16 2460 2462 O
cell 17 21 2463 2467 B-treatment
transplant 22 32 2468 2478 I-treatment
prior 33 38 2479 2484 O
to 39 41 2485 2487 O
or 42 44 2488 2490 O
after 45 50 2491 2496 O
the 51 54 2497 2500 O
primary 55 62 2501 2508 O
solitary 63 71 2509 2517 O
living 72 78 2518 2524 O
donor 79 84 2525 2530 O
liver 85 90 2531 2536 B-treatment
transplant 91 101 2537 2547 I-treatment

Participation 0 13 2548 2561 O
in 14 16 2562 2564 O
any 17 20 2565 2568 O
other 21 26 2569 2574 O
studies 27 34 2575 2582 O
that 35 39 2583 2587 O
involved 40 48 2588 2596 O
investigational 49 64 2597 2612 B-treatment
drugs 65 70 2613 2618 I-treatment
or 71 73 2619 2621 O
regimens 74 82 2622 2630 O
in 83 85 2631 2633 O
the 86 89 2634 2637 O
preceding 90 99 2638 2647 O
year 100 104 2648 2652 O

Positive 0 8 2653 2661 B-pregnancy
pregnancy 9 18 2662 2671 I-pregnancy
test 19 23 2672 2676 O

Prednisone 0 10 2677 2687 B-treatment
: 10 11 2687 2688 O
maximum 12 19 2689 2696 O
dose 20 24 2697 2701 O
of 25 27 2702 2704 O
5 28 29 2705 2706 B-upper_bound
mg 29 31 2706 2708 I-upper_bound
daily 32 37 2709 2714 O

Receipt 0 7 2715 2722 O
of 8 10 2723 2725 O
a 11 12 2726 2727 O
vaccination 13 24 2728 2739 B-treatment
within 25 31 2740 2746 O
14 32 34 2747 2749 B-upper_bound
days 35 39 2750 2754 I-upper_bound
prior 40 45 2755 2760 I-upper_bound
to 46 48 2761 2763 O
Treg 49 53 2764 2768 B-treatment
infusion 54 62 2769 2777 I-treatment

Risk 0 4 2778 2782 B-clinical_variable
Estimation 5 15 2783 2793 I-clinical_variable
of 16 18 2794 2796 I-clinical_variable
Tumor 19 24 2797 2802 I-clinical_variable
Recurrence 25 35 2803 2813 I-clinical_variable
After 36 41 2814 2819 I-clinical_variable
Transplant 42 52 2820 2830 I-clinical_variable
( 53 54 2831 2832 I-clinical_variable
RETREAT 54 61 2832 2839 I-clinical_variable
) 61 62 2839 2840 I-clinical_variable
Score 63 68 2841 2846 I-clinical_variable
less 69 73 2847 2851 O
than 74 78 2852 2856 O
or 79 81 2857 2859 O
equal 82 87 2860 2865 O
to 88 90 2866 2868 O
3 91 92 2869 2870 B-upper_bound

Screening 0 9 2871 2880 O
liver 10 15 2881 2886 B-treatment
biopsy 16 22 2887 2893 I-treatment
with 23 27 2894 2898 O
any 28 31 2899 2902 O
of 32 34 2903 2905 O
the 35 38 2906 2909 O
following 39 48 2910 2919 O
histological 49 61 2920 2932 O
criteria 62 70 2933 2941 O
, 70 71 2941 2942 O
as 72 74 2943 2945 O
determined 75 85 2946 2956 O
by 86 88 2957 2959 O
the 89 92 2960 2963 O
reading 93 100 2964 2971 O
of 101 103 2972 2974 O
a 104 105 2975 2976 O
central 106 113 2977 2984 O
pathologist 114 125 2985 2996 O

Serologic 0 9 2997 3006 O
evidence 10 18 3007 3015 O
of 19 21 3016 3018 O
human 22 27 3019 3024 B-chronic_disease
immunodeficiency 28 44 3025 3041 I-chronic_disease
1 45 46 3042 3043 B-lower_bound
or 47 49 3044 3046 O
2 50 51 3047 3048 B-upper_bound
infection 52 61 3049 3058 B-chronic_disease

Stable 0 6 3059 3065 O
liver 7 12 3066 3071 O
tests 13 18 3072 3077 O
, 18 19 3077 3078 O
defined 20 27 3079 3086 O
as 28 30 3087 3089 O
ALT 31 34 3090 3093 B-clinical_variable
and 35 38 3094 3097 O
either 39 45 3098 3104 O
alkaline 46 54 3105 3113 B-clinical_variable
phosphatase 55 66 3114 3125 I-clinical_variable
or 67 69 3126 3128 O
GGT 70 73 3129 3132 B-clinical_variable
either 74 80 3133 3139 O
within 81 87 3140 3146 O
normal 88 94 3147 3153 O
limits 95 101 3154 3160 O
OR 102 104 3161 3163 O
< 105 106 3164 3165 O
\\=1.5 106 112 3165 3171 O
X 113 114 3172 3173 O
baseline 115 123 3174 3182 O

Subject 0 7 3183 3190 O
received 8 16 3191 3199 O
at 17 19 3200 3202 O
least 20 25 3203 3208 O
100 26 29 3209 3212 B-lower_bound
x 30 31 3213 3214 I-lower_bound
10 32 34 3215 3217 I-lower_bound
^ 34 35 3217 3218 I-lower_bound
6 35 36 3218 3219 I-lower_bound
darTregs 37 45 3220 3228 I-lower_bound

Systemic 0 8 3229 3237 B-chronic_disease
illness 9 16 3238 3245 I-chronic_disease
requiring 17 26 3246 3255 O
or 27 29 3256 3258 O
likely 30 36 3259 3265 O
to 37 39 3266 3268 O
require 40 47 3269 3276 O
recurrent 48 57 3277 3286 O
or 58 60 3287 3289 O
chronic 61 68 3290 3297 O
immunosuppression 69 86 3298 3315 B-treatment
( 87 88 3316 3317 I-treatment
IS 88 90 3317 3319 I-treatment
) 90 91 3319 3320 I-treatment
drug 92 96 3321 3325 I-treatment
use 97 100 3326 3329 O

Transplant 0 10 3330 3340 B-treatment
for 11 14 3341 3344 O
liver 15 20 3345 3350 B-chronic_disease
disease 21 28 3351 3358 I-chronic_disease
secondary 29 38 3359 3368 O
to 39 41 3369 3371 O
autoimmune 42 52 3372 3382 B-chronic_disease
disease 53 60 3383 3390 I-chronic_disease

autoimmune 0 10 3391 3401 B-chronic_disease
hepatitis 11 20 3402 3411 I-chronic_disease

male 0 4 3412 3416 B-gender

participants 0 12 3417 3429 O
with 13 17 3430 3434 O
reproductive 18 30 3435 3447 O
potential 31 40 3448 3457 O
must 41 45 3458 3462 O
agree 46 51 3463 3468 B-contraception_consent
to 52 54 3469 3471 I-contraception_consent
use 55 58 3472 3475 I-contraception_consent
effective 59 68 3476 3485 I-contraception_consent
methods 69 76 3486 3493 I-contraception_consent
of 77 79 3494 3496 I-contraception_consent
birth 80 85 3497 3502 I-contraception_consent
control 86 93 3503 3510 I-contraception_consent
for 94 97 3511 3514 O
the 98 101 3515 3518 O
duration 102 110 3519 3527 O
of 111 113 3528 3530 O
the 114 117 3531 3534 O
study 118 123 3535 3540 O

primary 0 7 3541 3548 B-chronic_disease
biliary 8 15 3549 3556 I-chronic_disease
cirrhosis 16 25 3557 3566 I-chronic_disease

primary 0 7 3567 3574 B-chronic_disease
sclerosing 8 18 3575 3585 I-chronic_disease
cholangitis 19 30 3586 3597 I-chronic_disease

with 0 4 3598 3602 O
tumor 5 10 3603 3608 B-cancer
burden 11 17 3609 3615 O
within 18 24 3616 3622 O
the 25 28 3623 3626 O
Milan 29 34 3627 3632 O
criteria 35 43 3633 3641 O

without 0 7 3642 3649 O
any 8 11 3650 3653 O
lesions 12 19 3654 3661 O
with 20 24 3662 3666 O
poorly 25 31 3667 3673 O
differentiated 32 46 3674 3688 O
HCC 47 50 3689 3692 B-cancer

without 0 7 3693 3700 O
cholangiocarcinoma 8 26 3701 3719 B-cancer
morphology 27 37 3720 3730 O

without 0 7 3731 3738 O
macro- 8 14 3739 3745 B-cancer
or 15 17 3746 3748 O
micro 18 23 3749 3754 B-cancer
- 23 24 3754 3755 I-cancer
vascular 24 32 3755 3763 I-cancer
invasion 33 41 3764 3772 I-cancer

α 0 1 3773 3774 B-clinical_variable
- 1 2 3774 3775 I-clinical_variable
fetoprotein 2 13 3775 3786 I-clinical_variable
( 14 15 3787 3788 I-clinical_variable
AFP 15 18 3788 3791 I-clinical_variable
) 18 19 3791 3792 I-clinical_variable
less 20 24 3793 3797 O
than 25 29 3798 3802 O
100 30 33 3803 3806 B-upper_bound
μg 34 36 3807 3809 I-upper_bound
/ 36 37 3809 3810 I-upper_bound
L 37 38 3810 3811 I-upper_bound
at 39 41 3812 3814 O
the 42 45 3815 3818 O
time 46 50 3819 3823 O
of 51 53 3824 3826 O
transplant 54 64 3827 3837 B-treatment

